Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Ponatinib

   Takeda

   Myeloid Leukemia, Chronic, Chronic Phase

   phase 2 · small molecule · completed

   1 trial →

2. Postoperative adjuvant lenvatinib

   The First People's Hospital of Lianyungang

   Hepatocellular Carcinoma (HCC)

   phase 2 · small molecule · active

   1 trial →

3. Pre-operative chemotherapy

   The First People's Hospital of Lianyungang

   Non-small Cell Lung Cancer

   phase 2 · small molecule · active

   1 trial →

4. Pre-operative chemotherapy

   Nanjing Zenshine Pharmaceuticals

   Gastric Cancers

   phase 2 · small molecule · active

   1 trial →

5. PreSave

   Fondazione Telethon ETS

   Muscle-Invasive Bladder cancer

   phase 2 · small molecule · active

   1 trial →

6. ProSpare

   United Therapeutics Europe Ltd

   Cancer

   phase 2 · other · active

   1 trial →

7. Probiotics Compound (Biolosion)

   Sun Yat-sen University

   Advanced Urothelial Carcinoma

   phase 2 · small molecule · active

   1 trial →

8. Prodige 54 SAMCO

   CERO THERAPEUTICS HOLDINGS, INC.

   COLORECTAL METASTATIC CANCER WITH MICROSATELLITE INSTABILITY

   phase 2 · small molecule · active

   1 trial →

9. Programmed Cell Death Protein 1 Inhibitor

   Chinese University of Hong Kong

   Locally Advanced Esophageal Squamous Cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

10. Prostate alone IMRT

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 2 · other · active

    1 trial →

11. Pucotenlimab

    Sun Yat-sen University

    Colorectal Cancer (CRC)

    phase 2 · small molecule · active

    1 trial →

12. Pucotenlimab

    Zhejiang Provincial People's Hospital

    Pancreatic Cancer

    phase 2 · mab · active

    1 trial →

13. Pulmonary Rehabilitation (PR)

    United Therapeutics Europe Ltd

    Non-small Cell Lung Cancer Stage III

    phase 2 · other · active

    1 trial →

14. Pyrotinib

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

15. QINLOCK 50 mg tablets

    Lacuna Pharma Pty Ltd

    Advanced gastrointestinal stromal tumor (GIST)

    phase 2 · small molecule · active

    1 trial →

16. QL1706

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Platinum-resistant Recurrent Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

17. QL1706

    The First People's Hospital of Lianyungang

    Local Advanced Esophageal Cancer

    phase 2 · small molecule · active

    1 trial →

18. QL1706 (Iparomlimab/Tuvonralimab)

    The First People's Hospital of Lianyungang

    Gastric Cancer Stage III

    phase 2 · small molecule · active

    1 trial →

19. QL1706 (bispecific antibody targeting PD-1 and CLTA-4)

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma (ESCC)

    phase 2 · small molecule · active

    1 trial →

20. QL1706-2025-086

    The First People's Hospital of Lianyungang

    Cervical Cancer Stage IVA

    phase 2 · other · active

    1 trial →

21. QUILT-2.005

    Immunitybio Ireland Limited

    Non-Muscle Invasive Bladder Cancer

    phase 2 · small molecule · active

    1 trial →

22. QUINTIS

    The George Institute

    Metastatic Colorectal Cancer without liver metastases

    phase 2 · small molecule · active

    1 trial →

23. Quemliclustat

    Arcus Biosciences

    Oligometastatic Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

24. Quizartinib

    Daiichi Sankyo

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

25. R10597-ONC-22114

    Lacuna Pharma Pty Ltd

    Melanoma, Advanced Solid Tumours, Clear-Cell Renal-Cell Carcinoma (ccRCC)

    phase 2 · small molecule · active

    1 trial →

26. R1979-ONC-1625

    Lacuna Pharma Pty Ltd

    B-cell non-Hodgkin lymphoma (NHL)

    phase 2 · small molecule · active

    1 trial →

27. R2810-ONC-2045

    Lacuna Pharma Pty Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

28. R2810-ONC-2268

    Lacuna Pharma Pty Ltd

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

29. R3767-ONC-2208

    Lacuna Pharma Pty Ltd

    Melanoma

    phase 2 · small molecule · active

    1 trial →

30. R3767-ONC-2266

    Lacuna Pharma Pty Ltd

    Resectable Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

31. R3767-ONC-2466

    Lacuna Pharma Pty Ltd

    Melanoma

    phase 2 · small molecule · active

    1 trial →

32. R4018-ONC-1721

    Lacuna Pharma Pty Ltd

    Fallopian Tube Cancer, Endometrial Cancer, Ovarian Cancer, Primary Peritoneal Cancer

    phase 2 · small molecule · active

    1 trial →

33. RC48-ADC

    Chinese University of Hong Kong

    Muscle Invasive Bladder Carcinoma

    phase 2 · small molecule · active

    1 trial →

34. RD14-01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor

    phase 2 · mab · active

    1 trial →

35. REFRaME-P1

    SUTRO BIOPHARMA, INC.

    Acute Myeloid Leukemia (AML)

    phase 2 · other · active

    1 trial →

36. REGN10597

    Regeneron UK Limited

    Melanoma

    phase 2 · small molecule · active

    1 trial →

37. REGN15505

    Regeneron UK Limited

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 · small molecule · active

    1 trial →

38. REGN2810

    Regeneron UK Limited

    Prostate Cancer Metastatic

    phase 2 · small molecule · active

    1 trial →

39. REGN4336

    Regeneron UK Limited

    Metastatic Castration-resistant Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

40. REGN5093

    Lacuna Pharma Pty Ltd

    MET-altered non-small cell lung cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

41. REGN5668

    Regeneron UK Limited

    Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

42. REGN5678

    Regeneron UK Limited

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 · small molecule · active

    1 trial →

43. REGN7075

    Regeneron UK Limited

    Advanced Solid Tumors

    phase 2 · small molecule · active

    1 trial →

44. RELUGOLIX

    Fondazione Telethon ETS

    Intermediate risk prostate cancer

    phase 2 · small molecule · active

    1 trial →

45. REO 029

    ONCOLYTICS BIOTECH INC

    Patients with advanced or metastatic gastrointestinal (GI) tumors.

    phase 2 · small molecule · active

    1 trial →

46. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic or Recurrent Squamous Cell Carcinoma of the Lung

    phase 2 · mab · completed

    1 trial →

47. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic Pancreatic Adenocarcinoma

    phase 2 · mab · completed

    1 trial →

48. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Metastatic Melanoma

    phase 2 · mab · completed

    1 trial →

Frequently asked questions